- Home
- ATCH vs LIPO Comparison
ATCH vs LIPO Comparison
Compare ATCH & LIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATCH
- LIPO
- Stock Information
- Founded
- ATCH 2022
- LIPO 2005
- Country
- ATCH United States
- LIPO United States
- Employees
- ATCH N/A
- LIPO N/A
- Industry
- ATCH
- LIPO Biotechnology: Pharmaceutical Preparations
- Sector
- ATCH
- LIPO Health Care
- Exchange
- ATCH Nasdaq
- LIPO Nasdaq
- Market Cap
- ATCH 3.2M
- LIPO 3.1M
- IPO Year
- ATCH N/A
- LIPO 2022
- Fundamental
- Price
- ATCH $0.21
- LIPO $2.99
- Analyst Decision
- ATCH
- LIPO
- Analyst Count
- ATCH 0
- LIPO 0
- Target Price
- ATCH N/A
- LIPO N/A
- AVG Volume (30 Days)
- ATCH 7.7M
- LIPO 39.2K
- Earning Date
- ATCH 05-16-2025
- LIPO 05-14-2025
- Dividend Yield
- ATCH N/A
- LIPO N/A
- EPS Growth
- ATCH N/A
- LIPO N/A
- EPS
- ATCH 2.67
- LIPO N/A
- Revenue
- ATCH N/A
- LIPO $519,866.00
- Revenue This Year
- ATCH N/A
- LIPO N/A
- Revenue Next Year
- ATCH N/A
- LIPO N/A
- P/E Ratio
- ATCH $0.08
- LIPO N/A
- Revenue Growth
- ATCH N/A
- LIPO 8.88
- 52 Week Low
- ATCH $0.18
- LIPO $1.97
- 52 Week High
- ATCH $83.99
- LIPO $12.00
- Technical
- Relative Strength Index (RSI)
- ATCH 33.79
- LIPO 58.50
- Support Level
- ATCH $0.19
- LIPO $2.75
- Resistance Level
- ATCH $0.23
- LIPO $3.17
- Average True Range (ATR)
- ATCH 0.02
- LIPO 0.29
- MACD
- ATCH 0.02
- LIPO 0.02
- Stochastic Oscillator
- ATCH 38.18
- LIPO 81.05
About ATCH AtlasClear Holdings Inc. Common Stock
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.